Anti-Sclerostin antibody [RM0129-4D77]
Be the first to review this product! Submit a review
|
(2 Publications)
Rat Monoclonal Sclerostin antibody. Suitable for WB and reacts with Mouse samples. Cited in 2 publications. Immunogen corresponding to Recombinant Full Length Protein corresponding to Mouse Sost.
View Alternative Names
Sclerostin, Sost
- WB
Supplier Data
Western blot - Anti-Sclerostin antibody [RM0129-4D77] (AB86465)
All lanes:
Western blot - Anti-Sclerostin antibody [RM0129-4D77] (ab86465) at 1/500 dilution
All lanes:
Mouse embryonic tissue
Predicted band size: 24 kDa
false
Reactivity data
Properties and storage information
Form
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Sclerostin inhibits osteoblastic activity and formation by interfering with bone morphogenetic proteins. It doesn’t form part of a large protein complex but interacts directly with cell surface receptors. Its expression decreases in response to mechanical loading on bones which is an important part of regulating bone density and remodeling. By controlling osteoblast function sclerostin contributes to skeletal homeostasis an essential process for maintaining bone strength and integrity.
Pathways
Several mechanisms regulate sclerostin activity. In the canonical Wnt/β-catenin signaling pathway it serves as an important checkpoint that ensures controlled bone formation. Sclerostin acts by preventing the activation of LRP5/6 receptors pivotal components in this pathway. Additionally it shares a regulatory network with dickkopf-1 (DKK1) another Wnt inhibitor both of which have an influence on bone metabolism and development.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (2)
Recent publications for all applications. Explore the full list and refine your search
Journal of molecular medicine (Berlin, Germany) 101:607-620 PubMed37121919
2023
Applications
Unspecified application
Species
Unspecified reactive species
Development (Cambridge, England) 146: PubMed31511252
2019
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com